Methodology of brain perfusion imaging

Journal of Magnetic Resonance Imaging

Volumn 13, Issue 4, 2001, Pages 496-520

  Barbier, Emmanuel L ^a   Lamalle, Laurent ^a,b   Décorps, Michel ^a,c  

^a INSERM   (France)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c HÔPITAL MICHALLON   (France)

Author keywords

Arterial spin labeling; Arterial spin tagging; Bolus tracking; Cerebral blood flow; Cerebral blood volume; Contrast agent; Dynamic susceptibility contrast; Functional imaging; Magnetic resonance imaging; Mean transit time; Neuroimaging; Review; Transit time

Indexed keywords

ARTICLE; BRAIN CIRCULATION; BRAIN PERFUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ELECTRON SPIN RESONANCE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STEADY STATE;

ANIMALS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, THEORETICAL; SPIN LABELS;

EID: 0035081242     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1073     Document Type: Article

References (246)

1. Relaxation effects in nuclear magnetic resonance absorption
2. Spin echoes
3. Nuclear resonance in flowing liquids
4. Fourier transform pulsed gradient spin-echo studies of molecular diffusion
5. Diffusion NMR imaging
6. Functional magnetic resonance imaging
7. Flow measurements by NMR
8. Flow in nuclear magnetic resonance imaging
9. Perfusion imaging by nuclear magnetic resonance
10. Perfusion imaging with NMR contrast agents
11. Susceptibility contrast imaging of cerebral blood volume: Human experience
12. Theoretical principles of perfusion imaging. Application to magnetic resonance imaging
13. Diffusion and perfusion magnetic resonance imaging in brain tumors
14. Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: Present utility and future promise
15. Magnetic resonance imaging of human brain function. Principles, practicalities, and possibilities
16. Contrast agents in functional MR imaging
17. NMR perfusion and metabolic imaging and some examples on brain tumours
18. Perfusion magnetic resonance imaging to assess brain tumor responses to new therapies
19. New magnetic resonance imaging methods for cerebrovascular disease: Emerging clinical applications
20. 3D bolus tracking with frequency-shifted BURST MRI
21. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging
22. Radiolabeled agents for SPECT imaging of brain perfusion
23. The influence of intravascular volume expansion on cerebral blood flow and blood volume in normal rats
24. Hypoxia increases velocity of blood flow through parenchymal microvascular systems in rat brain
25. The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo
26. Perfusion imaging
27. Deuterium magnetic resonance in vivo: The measurement of blood flow and tissue perfusion
28. Magnetic resonance imaging of perfusion using spin inversion of arterial water
29. In vivo MR measurements of regional arterial and venous blood volume fractions in intact rat brain
30. In vivo determination of absolute cerebral blood volume using hemoglobin as a natural contrast agent: An MRI study using altered arterial carbon dioxide tension
31. Contrast agents for cerebral perfusion MR imaging
32. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis
33. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results
34. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field
35. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T
36. Relaxation enhancement of the transverse magnetization of water protons in paramagnetic suspensions of red blood cells
37. Proton transverse nuclear magnetic relaxation in oxidized blood: A numerical approach
38. Water diffusion and exchange as they influence contrast enhancement
39. Ter Pogossian MM. Evidence of the limitations of water as a freely diffusible tracer in brain of the rhesus monkey
40. Quantitative magnetic resonance imaging of capillary water permeability and regional blood volume with an intravascular MR contrast agent
41. MR contrast due to intravascular magnetic susceptibility perturbations
42. Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging, A comparison of signal characteristics with a biophysical model
43. Intravascular susceptibility contrast mechanisms in tissues
44. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime
45. Microscopic susceptibility variation and transverse relaxation: Theory and experiment
46. Effects of biophysical and physiological parameters on brain activation-induced R2* and R2 changes: Simulations using a deterministic diffusion model
47. Analytical theory of susceptibility induced NMR signal dephasing in a cerebrovascular network
48. Analytical model of susceptibility-induced MR signal dephasing: Effect of diffusion in a microvascular network
49. MR contrast due to microscopically heterogeneous magnetic susceptibility: Numerical simulations and applications to cerebral physiology
50. Spin diffusion measurements: Spin-echoes in the presence of a time-dependent field gradient
51. Simultaneous measurement of ΔR2 and ΔR2* in cat brain during hypoxia and hypercapnia
52. Vessel size imaging
53. NMR imaging of changes in vascular morphology due to tumor angiogenesis
54. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients
55. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted Turbo-FLASH imaging
56. Indicator transit time considered as a gamma-variate
57. On the theory of the indicator-dilution method for measurement of blood flow and volume
58. Theoretical basis of indicator dilution methods for measuring flow and volume
59. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast enhanced MR imaging
60. A single-step method for estimation of local cerebral blood volume from susceptibility contrast MRI images
61. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques
62. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: Comparison of methodologies
63. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI
64. Perfusion imaging with echoplanar imaging
65. Reversed spiral imaging for increased T2* contrast
66. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies
67. Comparison of echo-planar sequences for perfusion-weighted MRI which is best?
68. Optimization of fast acquisition methods for whole-brain relative cerebral blood volume (rCBV) mapping with susceptibility contrast agents
69. Benefits and pitfalls of keyhole imaging, especially in first-pass perfusion studies
70. Measurement of brain activity with bolus administration of contrast agent and echo MR imaging
71. Sequential dynamic susceptibility contrast MR experiments in human brain: Residual contrast agent effect, steady state, and hemodynamic perturbation
72. Comparison of MR perfusion imaging and microsphere measurements of regional cerebral blood flow in a rat model of middle cerebral artery occlusion
73. Assessment of whole-brain vasodilatory capacity with acetazolamide challenge at 1.5 T using dynamic contrast imaging with frequency-shifted burst
74. Simultaneous blood flow, blood volume and blood brain barrier permeability mapping using Gd-based contrast agents
75. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images
76. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction
77. Simultaneous dynamic measurement of tissue contrast enhancement and perfusion at 0.5 Tesla: Method and postprocessing
78. Dual dynamic contrast-enhanced MR imaging
79. Tumor characterization with dynamic contrast enhanced MRI using MR contrast agents of various molecular weights
80. Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit
81. Cerebral blood volume maps with dynamic contrast-enhanced T1-weighted FLASH imaging: Normal values and preliminary clinical results
82. Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors
83. Improved contrast agent bolus tracking using T1 FARM
84. Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats
85. Functional mapping of the human visual cortex by magnetic resonance imaging
86. Tumor vascularity in the brain; evaluation with dynamic susceptibility-contrast MR imaging
87. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: A preliminary analysis
88. Dynamic contrast-enhanced T2*-weighted MRI in patients with cerebrovascular disease
89. Imaging developing brain infarction
90. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin
91. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings
92. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors
93. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors
94. Hyperacute stroke: Ultrafast MR imaging to triage patients prior to therapy
95. Hyperacute stroke: Simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time
96. Cerebral hemodynamics in human acute ischemic stroke: A study with diffusion- and perfusion-weighted magnetic resonance imaging and SPECT
97. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time?
98. Contrast-reduced imaging of tissue concentration and arterial level (CRITICAL) for assessment of cerebral hemodynamics in acute stroke by magnetic resonance
99. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent
100. Hypercarbia-induced changes in cerebral blood volume in the cat: A 1H MRI and intravascular contrast agent study
101. In vivo regional cerebral blood volume: Quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging
102. Regional cerebral blood volume: A comparison of the dynamic imaging and the steady state methods
103. Continuous assessment of relative cerebral blood volume in transient ischemia using steady state susceptibility-contrast MRI
104. A study of the contribution of changes in the cerebral blood volume to the haemodynamic response to anoxia in rat brain
105. Quantitative measurements of regional cerebral blood volume using MRI in rats: Effects of arterial carbon dioxide tension and mannitol
106. Regional cerebral plasma volume response to carbon dioxide using magnetic resonance imaging
107. Comparison of static and dynamic MRI techniques for the measurement of regional cerebral blood volume
108. Quantitative magnetic resonance imaging in experimental hypercapnia: Improvement in the relation between changes in brain R2 and the oxygen saturation of venous blood after correction for changes in cerebral blood volume
109. Mapping drug-induced changes in cerebral R2* by multiple gradient recalled echo functional MRI
110. Regional cerebral blood volume response to hypocapnia using susceptibility contrast MRI
111. Titration of the BOLD effect: Separation and quantitation of blood volume and oxygenation changes in the human cerebral cortex during neuronal activation and ferumoxide infusion
112. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging
113. Use of T2-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain
114. CBF and CBV measurements by USPIO bolus tracking: Reproducibility and comparison with Gd-based values
115. Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): A steady-state contrast agent technique for measuring blood flow, relative blood volume fraction, and the water extraction fraction
116. Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension
117. The local circulation of the living brain: Values in the unanesthetized and anesthetized cat
118. 14Clantipyrine
119. Measurement of regional blood flow in cerebral cortex of man through the intact skull
120. HEADTOME: A hybrid emission tomograph for single photon and positron emission imaging of the brain
121. Regional cerebral blood flow determination using 133Xe and a standard rotating gamma-camera
122. 133Xe inhalation and external counting
123. Measurement of local cerebral blood flow and metabolism in man with positron emission tomography
124. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation
125. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans
126. The determination of cerebral blood flow in man by use of nitrous oxide in low concentrations
127. Deuterium nuclear magnetic resonance measurements of blood flow and tissue perfusion employing 2H2O as a freely diffusible tracer
128. In vivo 31P and 2H NMR studies of rat brain tumor pH and blood flow during acute hyperglycemia: Differential effects between subcutaneous and intracerebral locations
129. Quantification of regional blood flow by monitoring of exogenous tracer via nuclear magnetic resonance spectroscopy
130. Measurement of regional cerebral blood flow in cat brain using intracarotid 2H2O and 2H NMR imaging
131. Simultaneous measurement of cerebral blood flow and energy metabolites in piglets using deuterium and phosphorus nuclear magnetic resonance
132. Concurrent measurements of cerebral blood flow, sodium, lactate, and high-energy phosphate metabolism using 19F, 23Na, 1H, and 31P nuclear magnetic resonance spectroscopy
133. Non-invasive determination of cerebral blood flow changes by 19F NMR spectroscopy
134. Cerebral blood flow measured by NMR indicator dilution in cats
135. Acute toxicity of a nuclear magnetic resonance cerebral blood flow indicator in cats
136. 19F magnetic resonance imaging of cerebral blood flow with 0.4-cc resolution
137. Use of 19F NMR spectroscopy for measurement of cerebral blood flow: A comparative study using microsphere
138. Oxygen-17: A physiological, biochemical and anatomical MRI contrast agent
139. Oxygen-17 compounds as potential NMR T2 contrast agents: Enrichment effects of H2(17)O on protien solution and living tissues
140. In vivo measurement of cerebral oxygen consumption and blood flow using 170 magnetic resonance imaging
141. Cerebral oxygen utilization analyzed by the use of oxygen-17 and its nuclear magnetic resonance
142. In vivo oxygen-17 nuclear magnetic resonance for the estimation of cerebral blood flow and oxygen consumption
143. Proton relaxation in pure liquids and in liquids containing paramagnetic gases in solution
144. Nuclear magnetic resonance study of the proton transfer in water
145. Proton NMR imaging of cerebral blood flow using H2(17)O
146. Measurement of local cerebral blood flow by magnetic resonance Imaging: In vivo autoradiographic stategy using 170 -labeled water
147. Brain MRI with laser-polarized 129Xe
148. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation
149. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo
150. Measuring cerebral blood flow using magnetic resonance imaging techniques
151. A general kinetic model for quantitative perfusion imaging with arterial spin labeling
152. What is the correct value for the brain - Blood partition coefficient for water?
153. Magnetic resonance imaging of the brain-blood partition coefficient for water: Application to spin-tagging measurement of perfusion
154. Magnetic resonance imaging of perfusion in the isolated rat heart using spin inversion of arterial water
155. Projection angiograms of blood labeled by adiabatic fast passage
156. Measurement of rat brain perfusion by NMR using spin labeling of arterial water: In vivo determination of the degree of spin labeling
157. Measurement of brain perfusion by volume-localized NMR spectroscopy using inversion of arterial water spins: Accounting for transit time and cross-relaxation
158. The efficiency of adiabatic inversion for perfusion imaging by arterial spin labeling
159. A model of the inversion process in an arterial inversion experiment
160. Effect of magnetization transfer on the measurement of cerebral blood flow using steady-state arterial spin tagging approaches: Atheoretical investigation
161. NMR measurement of perfusion using arterial spin labeling without saturation of macromolecular spins
162. Estimation of water extraction fractions in rat brain using magnetic resonance measurement of perfusion with arterial spin labeling
163. Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water
164. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling
165. Multi-slice perfusion MRI using continuous arterial water labeling controlling for MT effects with simultaneous proximal and distal RF irradiation
166. Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling
167. Multislice perfusion and perfusion territory imaging in humans with separate label and image coils
168. A strategy to optimize the signal-to-noise ratio in one-coil arterial spin tagging perfusion imaging
169. A quantitative analysis of alternated line scanning in k space and its application in MRI of regional tissue perfusion by arterial spin labeling
170. Perfusion imaging with compensation for asymetric magnetization transfer effects
171. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques
172. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging
173. A quantitative interpretation of IVIM measurements of vascular perfusion in the rat brain
174. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping
175. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow
176. 1-weighted echo-planar imaging
177. Quantitative magnetic resonance imaging of perfusion using magnetic labeling of water proton spins within the detection slice
178. Perfusion imaging by un-inverted flow-sensitive alternating inversion recovery (UNFAIR)
179. BASE imaging: A new spin labeling technique for measuring absolute perfusion changes
180. MR perfusion imaging of pulmonary parenchyma using pulsed arterial spin labeling techniques: FAIRER and FAIR
181. FAIR excluding radiation damping (FAIRER)
182. Qualitative mapping of cerebral blood flow and functional localization with echo-planar imaging and signal targeting with alternating radio frequency
183. STAR-HASTE: Perfusion imaging without magnetic susceptibility artifact
184. EPISTAR MRI: Multislice mapping of cerebral blood flow
185. Transfer insensitive labeling technique (TILT): Application to multislice functional perfusion imaging
186. Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling
187. Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II)
188. QUIPSS II with thin-slice TI1 periodic saturation: A method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling
189. A model for quantification of perfusion in pulsed labeling techniques
190. Simultaneous multislice acquisition with arterial-flow tagging (SMART) using echo planar imaging (EPI)
191. Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin labeling
192. Perfusion imaging using FOCI RF pulses
193. Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST)
194. Multiple inversion recovery reduces static tissue signal in angiograms
195. Perfusion analysis using dynamic arterial spin labeling (DASL)
196. Simultaneous measurement of perfusion and vascular blood fraction using dynamic arterial spin labeling (DASL)
197. Spin echo entrapped perfusion image (SEEPAGE). A nonsubtraction method for direct imaging of perfusion
198. Perfusion-weighted "single-trial" fMRI
199. Evidence for the exchange of arterial spin-labeled water with tissue water in rat brain from diffusion sensitized measurements of perfusion
200. Effect of restricted water exchange on cerebral blood flow values calculated with arterial spin tagging: A theoretical investigation
201. The single-coil arterial spin-tagging experiment for estimating cerebral blood flow as viewed from the capillary. What is the effective T1 of the experiment?
202. Water extraction fraction and permeability-surface product after intravenous injection in rats
203. Extraction of water labeled with oxygen 15 during single-capillary transit. Influence of blood pressure, osmolarity, and blood-brain barrier damage
204. Early perfusion after controlled cortical impact in rats: Quantification by arterial spin-labelled MRI and the influence of spin-lattice relaxation time heterogeneity
205. Brain magnetic resonance imaging with contrast dependent on blood oxygenation
206. Radioactive microsphere validation of a volume localized continuous saturation perfusion measurement
207. Validation of the FAIR technique of perfusion quantification with hydrogen clearance
208. A direct comparison between MRI arterial spin-tagging and quantitative autoradiography for measured cerebral blood flow in rats with experimental cerebral ischemia
209. Validation of arterial spin tagging perfusion using MR imaging: Corelation with autoradiographic CBF data
210. H2150 PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans
211. Quantitative measurements of cerebral blood flow in rats using the FAIR technique: Correlation with previous iodoantipyrine autoradiographic studies
212. Perfusion magnetic resonance imaging with continuous arterial spin labeling: Methods and clinical application in the central nervous system
213. Ultrafast perfusion-weighted MRI of functional brain activation in rats during forepaw stimulation: Comparison with T2-weighted MRI
214. Quantitation of regional cerebral blood flow increases during motor activation: A steady-state arterial spin tagging study
215. A FAIR study of motor cortex activation under normo- and hypercapnia induced by breath challenge
216. Comparison of simultaneously measured perfusion and BOLD signal increases during brain activation with T1-based tissue identification
217. Comparison of blood oxygenation and cerebral blood flow effects in fMRI: Estimation of relative oxygen consumption change
218. Simultaneous oxygenation and perfusion imaging study of functional activity in primary visual cortex at different visual stimulation frequency: CBF changes
219. Simultaneous blood oxygenation level-dependent and cerebral blood flow functional magnetic resonance imaging during forepaw stimulation in the rat
220. Cerebral perfusion and arterial transit time changes during task activation determined with continuous arterial spin labeling
221. Intracranial gradient-echo and spin-echo functional MR angiography in humans
222. Simultaneous glutamate and perfusion fMRI responses to regional brain stimulation
223. Assessment of cerebral blood flow and CO2 reactivity after controlled cortical impact by perfusion magnetic resonance imaging using arterial spin-labeling in rats
224. Characterization of cerebral blood flow during anesthesia with fentanyl, isoflurane, or pentobarbital in normal rats
225. Quantification of cerebral blood flow by bolus tracking and artery spin tagging methods
226. Temporal evolution and spatial distribution of the diffusion constant of water in rat brain after transient middle cerebral artery occlusion
227. The effect of hypothermia on transient focal ischemia in rat brain evaluated by diffusion- and perfusion-weighted NMR imaging
228. Reperfusion after thrombolytic therapy of embolic stroke in the rat: Magnetic resonance and biochemical imaging
229. Diffusion, perfusion, and T2 magnetic resonance imaging of anti-intercellular adhesion molecule 1 antibody treatment of transient middle cerebral artery occlusion in rat
230. Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5 T
231. Comparison of EPISTAR and T2*-weighted gadolinium-enhanced perfusion imaging in patients with acute cerebral ischemia
232. Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis
233. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling
234. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging
235. Noninvasive perfusion imaging of human brain tumors with EPISTAR
236. Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration
237. Imaging blood flow in brain tumors using arterial spin labeling
238. Regional cerebral blood volume and hematocrit measured in normal human volunteers by single-photon emission computed tomography
239. Measurement of cerebral blood flow and volume with positron emission tomography during isoflurane administration in the hypocapnic baboon
240. Determination of rat cerebral cortical blood volume changes by capillary mean transit time analysis during hypoxia, hypercapnia and hyperventilation
241. Microwave fixation for the determination of cerebral blood volume in rats
242. Decreases in regional cerebral blood flow with normal aging